Lawton W. Fitt
Associated companies
Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 17, 2026
Carlyle Schedules Q3 Earnings as Shares Fall and Targets Cut. Carlyle Secured Lending has scheduled its Q3 earnings release and conference call for the quarter ended September 30, 2026. In recent trading, the company's shares fell, as reported in a market roundup. Analysts at UBS and TD Cowen lowered their price targets to $60 and $42, citing concerns such as the risk of private‑credit exposure to a growing AI financing wave that Carlyle highlighted.
Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 17, 2026
Ciena Valuation in Focus as AI Growth is Largely Priced In. Recent analyses suggest that Ciena's successful diversification into artificial intelligence has been largely priced into the stock, which trades at a high multiple despite its cyclical nature. Meanwhile, sector peers like Ericsson and Taiwan Semiconductor report strong quarterly results, reflecting robust demand in telecommunications infrastructure. This environment keeps the focus on whether Ciena's premium valuation aligns with its growth trajectory.
Transaction History
| PGR | ▲ Buy | Grant | 3,093 | $0 | 5/8/2026 | View on chart |
| CG | ▲ Buy | Grant | 4,450 | $0 | 5/1/2026 | View on chart |
| PGR | ▼ Sell | Other | 1,986 | $0 | 4/10/2026 | View on chart |
| CIEN | ▲ Buy | Grant | 605 | $0 | 3/26/2026 | View on chart |
| CIEN | ▲ Buy | Grant | 257 | $0 | 3/26/2026 | View on chart |
| PGR | ▲ Buy | Grant | 1,986 | $0 | 5/9/2025 | View on chart |
| CG | ▲ Buy | Grant | 5,235 | $0 | 5/1/2025 | View on chart |
| PGR | ▼ Sell | Other | 2,619 | $0 | 4/11/2025 | View on chart |
| CIEN | ▲ Buy | Grant | 3,738 | $0 | 3/27/2025 | View on chart |
| CIEN | ▲ Buy | Grant | 1,590 | $0 | 3/27/2025 | View on chart |
| PGR | ▲ Buy | Grant | 2,619 | $0 | 5/10/2024 | View on chart |
| CG | ▲ Buy | Grant | 5,004 | $0 | 5/1/2024 | View on chart |
| PGR | ▼ Sell | Other | 3,898 | $0 | 4/12/2024 | View on chart |
| CIEN | ▲ Buy | Grant | 4,438 | $0 | 3/21/2024 | View on chart |
| PGR | ▲ Buy | Grant | 3,898 | $0 | 5/12/2023 | View on chart |
| CG | ▲ Buy | Grant | 6,238 | $0 | 5/1/2023 | View on chart |
| PGR | ▼ Sell | Other | 4,739 | $0 | 4/13/2023 | View on chart |
| CIEN | ▲ Buy | Grant | 4,331 | $0 | 3/30/2023 | View on chart |
| PGR | ▲ Buy | Grant | 4,739 | $0 | 5/16/2022 | View on chart |
| CG | ▲ Buy | Grant | 5,236 | $0 | 5/1/2022 | View on chart |
| PGR | ▼ Sell | Other | 4,802 | $0 | 4/7/2022 | View on chart |
| CIEN | ▲ Buy | Grant | 3,722 | $0 | 3/31/2022 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 17, 2026
Progressive Q3 Results Show Strong Underwriting, Slower Profit Growth
Progressive's Q3 earnings highlighted robust underwriting, but profit growth slowed compared to prior periods. In response, several analysts trimmed their price targets, with Wells Fargo cutting to $196 and Keefe, Bruyette & Woods to $246. The stock sits near a key support level of $196.44, a level that has been tested ten times in recent trading.
Progressive Q3 Results Show Strong Underwriting, Slower Profit Growth. Progressive's Q3 earnings highlighted robust underwriting, but profit growth slowed compared to prior periods. In response, several analysts trimmed their price targets, with Wells Fargo cutting to $196 and Keefe, Bruyette & Woods to $246. The stock sits near a key support level of $196.44, a level that has been tested ten times in recent trading.